Mohit S. Verma, Michael J. Fink, Gabriel L. Salmon, Nadine Fornelos, Takahiro E. Ohara, Stacy H. Ryu, Hera Vlamakis, Ramnik J. Xavier, Thaddeus S. Stappenbeck, George M. Whitesides
文献索引:10.1021/acschembio.8b00073
全文:HTML全文
Two biological activities of butyrate in the colon (suppression of proliferation of colonic epithelial stem cells and inflammation) correlate with inhibition of the activity of histone deacetylases. Cellular and biochemical studies of molecules similar in structure to butyrate, but different in molecular details (functional groups, chain-length, deuteration, oxidation level, fluorination, or degree of unsaturation), demonstrated that these activities were sensitive to molecular structure, and were compatible with the hypothesis that butyrate acts by binding to the Zn2+ in the catalytic site of histone deacetylases. Structure–activity relationships drawn from a set of 36 compounds offer a starting point for the design of new compounds targeting the inhibition of histone deacetylases. The observation that butyrate was more potent than other short-chain fatty acids is compatible with the hypothesis that crypts evolved (at least in part), to separate stem cells at the base of crypts from butyrate produced by commensal bacteria.
Crystallographic Trapping of Reaction Intermediates in Quino...
2018-04-19 [10.1021/acschembio.7b01104] |
Substrate Recognition by a Colistin Resistance Enzyme from M...
2018-04-19 [10.1021/acschembio.8b00116] |
Identification of the First Diketomorpholine Biosynthetic Pa...
2018-04-17 [10.1021/acschembio.8b00024] |
Dynamics, Conformational Entropy, and Frustration in Protein...
2018-04-16 [10.1021/acschembio.7b01105] |
O-GlcNAcase fragment discovery with fluorescence polarimetry
2018-04-11 [10.1021/acschembio.8b00183] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved